Position in FULC
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,176,148
+$421,591 QoQ
Shares Held
153,344
+129.8% QoQ
Ownership
0.230%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#47
of 168 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Y-Intercept (Hong Kong) Ltd holds $167,724,147 across 89 Biotechnology names. FULC ranks #47 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,829 | $15,999,081 | |
| 2 | ADMA |
Adma Biologics, Inc.
|
1,075,422 | $9,689,552 | |
| 3 | UPB |
Upstream Bio, Inc.
|
1,000,631 | $9,005,679 | |
| 4 | ANNX |
Annexon, Inc.
|
1,319,913 | $7,312,318 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
85,388 | $4,965,312 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
218,354 | $4,574,516 | |
| 7 | INCY |
Incyte Corp
|
47,833 | $4,502,041 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
78,338 | $4,425,313 |
All Filings in FULC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,176,148 | 153,344 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $754,557 | 66,716 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $103,702 | 11,272 | Shares | Sole | 2025-10-31 | |
| 2025-03-31 | $92,407 | 32,086 | Shares | Sole | 2025-05-06 | |
| 2024-09-30 | $253,837 | 71,103 | Shares | Sole | 2024-11-15 | |
| 2024-03-31 | $513,687 | 54,416 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $110,821 | 16,418 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $203,237 | 61,587 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $84,539 | 29,663 | Shares | Sole | 2023-05-09 | |
| No filing history on record for this holder in this stock. | ||||||